AMLX peer analysis
Amylyx Pharmaceuticals (AMLX) against its competitors: price, today's move, 1-year return and market value side by side.
AMLX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACIU AC Immune | $2.11 | -7.86% | -38.48% | $209.79M |
| AVXL Anavex Life Sciences | $1.15 | 3.60% | -84.68% | $102.89M |
| CLNN Clene | $3.97 | -3.17% | -63.17% | – |
| DNLI Denali Therapeutics | $20.16 | 2.23% | 34.32% | $3.16B |
| ELDN Eledon Pharmaceuticals | $2.60 | 5.89% | -37.84% | – |
| IONS Ionis Pharmaceuticals | $39.20 | 1.03% | -47.91% | $6.45B |
| NRSN NeuroSense Therapeutics | $1.40 | -1.76% | -93.35% | – |
| PMN ProMIS Neurosciences | $4.10 | 12.33% | -59.31% | – |
| PRAX Praxis Precision Medicines | $279.00 | 6.25% | 59.14% | – |
| PRTA Prothena | $7.97 | 1.01% | -23.17% | $405.05M |
| AMLX Amylyx Pharmaceuticals | $30.16 | 9.20% | 109.59% | – |
- AMLX's peers: ACIU (AC Immune), AVXL (Anavex Life Sciences), CLNN (Clene), DNLI (Denali Therapeutics), ELDN (Eledon Pharmaceuticals), IONS (Ionis Pharmaceuticals), NRSN (NeuroSense Therapeutics), PMN (ProMIS Neurosciences).
Updated 2026-11-07 11:54 UTC